For Nanog (Figure 1H), all treatments were associated with decreased IHC scores (P < 0.05) in preneoplasias, while in adenomas fulvestrant was effective (P < 0.024), but not anastrozole (n.s.), and the combination treatment was also effective (P < 0.0002). The gene discussed is NANOG; the disease is adenoma.